On the other hand, we see an increase in risk-weighted assets up to the crisis, with a slight drop afterwards and the trend steadying since then. The deal will free up capital of some EUR 400 million, primarily by reducing risk-weighted assets by EUR 4.
The Heska Corporation is involved in biotechnical research for the development of vaccines and related diagnostic products for companion animals. The company manufactures health care products for dogs, cats, and horses and markets them to veterinarians.
Company Overview. Heska Imaging US, LLC designs, develops, and supplies veterinary digital radiography systems for healthcare professionals in the United States and internationally. It offers digital X-ray and ultrasound solutions for equine and small animals.